Profile | GDS4284 / 209058_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 9460.46 | 97 |
GSM687648 | Patient 402 control | 10758.4 | 97 |
GSM687653 | Patient 403 control | 10809.5 | 97 |
GSM687658 | Patient 404 control | 10563.1 | 97 |
GSM687663 | Patient 411 control | 10697.4 | 97 |
GSM687668 | Patient 422 control | 10957.8 | 97 |
GSM687673 | Patient 424 control | 9654.8 | 97 |
GSM687678 | Patient 425 control | 10127.3 | 97 |
GSM687683 | Patient 427 control | 11308.2 | 98 |
GSM687688 | Patient 428 control | 12839.6 | 98 |
GSM687695 | Patient 441 control | 4796.93 | 93 |
GSM687699 | Patient 443 control | 7359.01 | 96 |
GSM687704 | Patient 444 control | 9327.2 | 97 |
GSM687707 | Patient 448 control | 8584.02 | 96 |
GSM687712 | Patient 449 control | 10221.2 | 97 |
GSM687719 | Patient 450 control | 8375.37 | 96 |
GSM687724 | Patient 451 control | 8238.79 | 96 |
GSM687728 | Patient 452 control | 7570.6 | 96 |
GSM687646 | Patient 401 treated 24h | 11042.7 | 98 |
GSM687649 | Patient 402 treated 24h | 9295.19 | 97 |
GSM687665 | Patient 411 treated 24h | 9183.84 | 97 |
GSM687651 | Patient 402 treated 4 weeks | 10124.4 | 97 |
GSM687667 | Patient 411 treated 4 weeks | 10601.8 | 97 |
GSM687670 | Patient 422 treated 24h | 10303.4 | 97 |
GSM687671 | Patient 422 treated 4 weeks | 10720 | 97 |
GSM687654 | Patient 403 treated 24h | 11918.4 | 98 |
GSM687675 | Patient 424 treated 24h | 9845.4 | 97 |
GSM687685 | Patient 427 treated 24h | 12241.5 | 98 |
GSM687656 | Patient 403 treated 4 weeks | 9591.73 | 97 |
GSM687677 | Patient 424 treated 4 weeks | 12375.1 | 98 |
GSM687687 | Patient 427 treated 4 weeks | 10561.8 | 97 |
GSM687692 | Patient 428 treated 4h | 11063.6 | 97 |
GSM687716 | Patient 449 treated 4h | 11405.4 | 97 |
GSM687722 | Patient 450 treated 4h | 9343.27 | 97 |
GSM687680 | Patient 425 treated 24h | 10871 | 97 |
GSM687690 | Patient 428 treated 24h | 10654.6 | 97 |
GSM687700 | Patient 443 treated 24h | 6630.92 | 95 |
GSM687705 | Patient 444 treated 24h | 13339.4 | 98 |
GSM687714 | Patient 449 treated 24h | 10394 | 97 |
GSM687721 | Patient 450 treated 24h | 6649.78 | 95 |
GSM687682 | Patient 425 treated 4 weeks | 12750.5 | 98 |
GSM687694 | Patient 428 treated 4 weeks | 11809.6 | 98 |
GSM687702 | Patient 443 treated 4 weeks | 9564.09 | 97 |
GSM687718 | Patient 449 treated 4 weeks | 14306.3 | 98 |
GSM687723 | Patient 450 treated 4 weeks | 10337.3 | 97 |
GSM687661 | Patient 404 treated 4h | 11302.7 | 98 |
GSM687710 | Patient 448 treated 4h | 9700.59 | 97 |
GSM687726 | Patient 451 treated 4h | 7386.8 | 96 |
GSM687730 | Patient 452 treated 4h | 40124.2 | 99 |
GSM687660 | Patient 404 treated 24h | 6425.93 | 95 |
GSM687697 | Patient 441 treated 24h | 5830.04 | 95 |
GSM687709 | Patient 448 treated 24h | 8419.48 | 96 |
GSM687725 | Patient 451 treated 24h | 7458.09 | 96 |
GSM687729 | Patient 452 treated 24h | 3664.6 | 91 |
GSM687727 | Patient 451 treated 4 weeks | 9182.28 | 97 |
GSM687731 | Patient 452 treated 4 weeks | 7994.72 | 96 |